Gamma-Camera Direct Imaging of the Plasma and On/Intra Cellular Distribution of the

Maria-Argyro Karageorgou, Adamantia Apostolopoulou, Mina-Ermioni Tomazinaki, Dragana Stanković, Efstathios Stiliaris, Penelope Bouziotis, Dimosthenis Stamopoulos

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria-Argyro KarageorgouDepartment of Physics, School of Science, National and Kapodistrian University of Athens, 15784 Athens, Greece.ORCID 0000-0001-5507-2958

Adamantia ApostolopoulouInstitute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research "Demokritos", 15341 Athens, Greece.

Mina-Ermioni TomazinakiDepartment of Physics, School of Science, National and Kapodistrian University of Athens, 15784 Athens, Greece.

Dragana StankovićLaboratory for Radioisotopes, "Vinča" Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, Serbia.ORCID 0000-0001-7669-2865

Efstathios StiliarisDepartment of Physics, School of Science, National and Kapodistrian University of Athens, 15784 Athens, Greece.

Penelope BouziotisInstitute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research "Demokritos", 15341 Athens, Greece.ORCID 0000-0001-6778-2201

Dimosthenis StamopoulosDepartment of Physics, School of Science, National and Kapodistrian University of Athens, 15784 Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The radiolabeled iron oxide nanoparticles constitute an attractive choice to be used as dual-modality contrast agents (DMCAs) in nuclear medical diagnosis, due to their ability to combine the benefits of two imaging modalities, for instance single photon emission computed tomography (SPECT) with magnetic resonance imaging (MRI). Before the use of any DMCA, the investigation of its plasma extra- and on/intra cellular distribution in peripheral human blood is of paramount importance. Here, we focus on the in vitro investigation of the distribution of

Indexed as

biocompatibilitycellular distributiondual-modality contrast agentgamma-camera imagingiron oxide nanoparticlesperipheral human bloodtechnetium-99m

Identifiers

PMID38255503

DOI10.3390/ma17020335

PMCPMC10820996

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.